RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
151 hedge funds and large institutions have $704M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 49 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
-30
Holders Change %
-16.57%
% of All Funds
2.33%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
34
Increased
49
Reduced
49
Closed
62
Calls
$18.7M
Puts
$13.6M
Net Calls
+$5.19M
Net Calls Change
+$60.5M
